For more than a decade, hospitals have worked to help older adults avoid repeated inpatient stays, incentivized by a federal program that cuts Medicare reimbursements if hospitals have higher-than-expected rates of readmissions ...
Jan 22, 2026
0
20
Having an ischemic stroke during pregnancy or three months after pregnancy is associated with an increased risk of cardiovascular events like heart attack or second stroke, heart disease and depression later in life, according ...
Jan 21, 2026
0
0
Recent findings have shown that routine eye screening could also be used for early detection of underlying heart disease in people with type 2 diabetes.
Jan 20, 2026
0
0
Scientists have discovered an answer to the longstanding mystery of why more than half of patients with chronic kidney disease ultimately die of cardiovascular problems: Their kidneys produce a substance that poisons the ...
Jan 20, 2026
0
0
Pioneering research by experts at the University of Sydney, the Baird Institute and the Royal Prince Alfred Hospital in Sydney has shown that heart muscle cells regrow after a heart attack, opening up the possibility of new ...
Jan 19, 2026
0
188
Anthracyclines are among the most widely used chemotherapy drugs and have been a mainstay of cancer treatment for more than 30 years. Their extraordinary efficacy against numerous solid and hematologic tumors means that they ...
Jan 15, 2026
0
0
Using nearly a decade of data (2015–2023) from 800+ U.S. hospitals and more than 700,000 patients, Northwestern researchers found that when Asian American heart failure patients are separated by ethnicity, rather than grouped ...
Jan 14, 2026
0
1
Through its commitment to a data-driven approach to improving cardiovascular health, the Journal of the American College of Cardiology published the first JACC Cardiovascular Statistics report. This comprehensive analysis ...
Jan 12, 2026
0
0
About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood called clonal hematopoiesis of indeterminate potential (CHIP). A study by Vanderbilt Health researchers ...
Jan 8, 2026
0
0
The U.S. Food and Drug Administration has approved Myqorzo (aficamten) for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Approval of Myqorzo was granted to Cytokinetics.
Jan 6, 2026
0
0
